期刊文献+

利用噬菌体肽库技术筛选卵巢特异的VEGFR3亲和肽 被引量:7

Screening the peptide high-binding VEGF receptor 3 with phage-displayed random peptide library
在线阅读 下载PDF
导出
摘要 目的从噬菌体12肽库中筛选VEGFR3胞外区蛋白高亲和肽作为卵巢癌淋巴管上皮细胞潜在靶向载体。方法用噬菌体展示固相结合法,生物淘选与扩增。经过4个循环的筛选,利用ELISA法鉴定噬菌体单克隆的亲和性,测定亲和力高的阳性噬菌体融合蛋白的DNA序列,竞争法ELISA检测优势克隆与靶蛋白的特异性。结果经过4轮筛选,噬菌体出现良好的富集,选择8个阳性克隆测序,经测序5个克隆插入短肽是(WHGSLKQNLWWY),竞争性ELISA显示其与VEGFR3具有良好的亲合性,并能被VEGF-D分子抑制。结论噬菌体12肽库筛选的VEGFR3高亲和多肽(WHGSLKQNLWWY),可望成为靶向载体构建的结构基础。 Objective To get a high affinity peptide of vascular endothelial growth factor receptor 3 ( VEGFR3 ) as a potent carrier targeted to lymphangiogenesis of ovarian cancer via the technology of phage display. Methods Solid-phase was panned with direct VEGFR3 extracellular protein coating, then the unbound phage was washed away and the eluted phage was amplified. The positive phage clones were identified by ELISA and sequenced, and the affinity and specialty were identified by competent ELISA. Results After four-round bio-panning, the enriched positive phage clones were identified by ELISA. Eight positive phage clones were sequenced and 5 were consensus (WHGSLKQNLWWY). The short peptide displayed on screened positive phage could bind specifically to VEGFR3, and the binding could be inhibited by natural antibody VEGF-D. Conclusion The phage clone (phage-WHGSLKQNLWWY )obtained via bio-panning of peptide library has a high affinity with VEGF receptor 3. The peptide could be a potent carrier targeted to VEGFR3.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2006年第4期308-310,共3页 Journal of Third Military Medical University
基金 国家自然科学基金资助项目(30371484)~~
关键词 血管生长因子受体3 噬菌体展示 筛选 vascular endothelial growth factor recepter 3 peptide display bio-panning
作者简介 侍立峰(1977-),男,江苏省连云港市人,硕士研究生,医师,主要从事卵巢肿瘤方面的研究。电话:(023)65398434 通讯作者:梁志清,电话:(023)68754409
  • 相关文献

参考文献9

  • 1AL-RAWI M A,MANSEL R E,JIANG W G.Molecular and cellular mechanisms of lymphangiogenesis[J].Eur J Surg Oncol,2005,31(2):117-121.
  • 2UNDERINER T L,RUGGERI B,GINGRICH D E.Development of vascular endothelial growth factor receptor(VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy[J].Curr Med Chem,2004,11(6):731-745.
  • 3HE Y,KOZAKI K,KARPANEN T,et al.Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling[J].J Natl Cancer Inst,2002,94(11):819-825.
  • 4AKABANI G,MCLENDON R E,BIGNER D D,et al.Vascular targeted endoradiotherapy of tumors using alpha-particle-emitting compounds:theoretical analysis[J].Int J Radiat Oncol Biol Phys,2002,54(4):1259-1275.
  • 5YOKOYAMA Y,CHARNOCK-JONES D S,LICENCE D,et al.Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma[J].Br J Cancer,2003,88(2):237-244.
  • 6ACHEN M G,ROUFAIL S,DOMAGALA T,et al.Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3[J].Eur J Biochem,2000,267(9):2505-2515.
  • 7TERADA T,INUI K.Peptide transporters:structure,function,regulation and application for drug delivery[J].Curr Drug Metab,2004,5(1):85-94.
  • 8SZARDENINGS M.Phage display of random peptide libraries:applications,limits,and potential[J].J Recept Signal Transduct Res,2003,23(4):307-349.
  • 9SMITH G P,PETRENKO V A.Phage display[J].Chem Rev,1997,97(2):391-410.

同被引文献65

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部